Awiqli
Insulin icodec-abae
- Strength
- 700 U/mL
- Form
- Injection, Solution
Novo Nordisk Pharmaceutical Industries, LP
Not stocked by us — reference only
Insulin icodec-abae
Listed by Novo Nordisk Pharmaceutical Industries, LP
| Dosage form | Injection, Solution |
|---|---|
| Route | Subcutaneous |
| Approval route | BLA — biologic licence |
| NDC code | 0169-3170 |
| FDA application | BLA761326 |
| Package sizes listed | 1 |
| Marketed since | August 2026 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Insulin icodec-abae
Novo Nordisk Pharmaceutical Industries, LP
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.